Skip navigation

Valeant Pharmaceuticals International Inc.

2016 Revenue (US$ Millions)$9,674
Revenue Growth (%)-7.39%
Net Income (US$ Millions)-$2,409
Earnings Per Share (US$)-$6.94
EPS Growth Rate (%)NM
Profit Margin-24.90%
Total Equity (US$ Millions)$3,152
Return on Equity (%)-40.75%
Long Term Debt (US$ Millions)$29,845
Debt To Equity Ratio (%)9.47%
Total Assets (US$ Millions)$43,529
Current Assets (US$ Millions)$5,077
Current Liabilities (US$ Millions)$3,609
Cost of Goods Sold (US$ Millions)$2,611
Inventory Turnover2.25